Systematic Review of Systemic and Neuraxial Effects of Acetaminophen in Preclinical Models of Nociceptive Processing

References

• Gaskin DJ, Richard P. The economic costs of pain in the United States. J Pain. 2012;13(8):715–724. doi:10.1016/j.jpain.2012.03.009
   PubMed Web of Science ®Google Scholar
• Haykal T, Barbarawi M, Zayed Y, et al. Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials. J Cancer Res Clin Oncol. 2019;145(7):1795–1809. doi:10.1007/s00432-019-02932-0
   PubMed Web of Science ®Google Scholar
• Honvo G, Leclercq V, Geerinck A, et al. Safety of topical non-steroidal anti-inflammatory drugs in osteoarthritis: outcomes of a systematic review and meta-analysis. Drugs Aging. 2019;36(Suppl 1):45–64. doi:10.1007/s40266-019-00661-0
   Web of Science ®Google Scholar
• Vranken JH. Elucidation of pathophysiology and treatment of neuropathic pain. Cent Nerv Syst Agents Med Chem. 2012;12(4):304–314. doi:10.2174/187152412803760645
   Google Scholar
• Baron R. Neuropathic pain: a clinical perspective. Handb Exp Pharmacol. 2009;194:3–30. doi:10.1007/978-3-540-79090-7_1
   PubMedGoogle Scholar
• Prescott LF. Paracetamol: past, present, and future. Am J Ther. 2000;7(2):143–147. doi:10.1097/00045391-200007020-00011
   Google Scholar
• Brune K, Renner B, Tiegs G. Acetaminophen/paracetamol: a history of errors, failures and false decisions. Eur J Pain. 2015;19(7):953–965. doi:10.1002/ejp.621
   PubMed Web of Science ®Google Scholar
• Brune K, Hinz B. Paracetamol, ibuprofen, or a combination of both drugs against knee pain: an excellent new randomised clinical trial answers old questions and suggests new therapeutic recommendations. Ann Rheum Dis. 2011;70(9):1521–1522. doi:10.1136/annrheumdis-2011-200242
   Web of Science ®Google Scholar
• Stephan BC, Parsa FD. Avoiding opioids and their harmful side effects in the postoperative patient: exogenous opioids, endogenous endorphins, wellness, mood, and their relation to postoperative pain. Hawaii J Med Public Health. 2016;75(3):63–67.
   PubMedGoogle Scholar
• McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol. 2018;84(10):2218–2230. doi:10.1111/bcp.13656
   PubMed Web of Science ®Google Scholar
• Nagai J, Uesawa Y, Shimamura R, Kagaya H. Characterization of the adverse effects induced by acetaminophen and nonsteroidal anti-inflammatory drugs based on the analysis of the Japanese adverse drug event report database. Clin J Pain. 2017;33(8):667–675. doi:10.1097/AJP.0000000000000457
   Web of Science ®Google Scholar
• Shankar SR. Intravenous acetaminophen in postoperative patients. JAMA. 2020;324(22):2327. doi:10.1001/jama.2020.21462
   Web of Science ®Google Scholar
• Dart RC, Green JL. The prescription paradox of acetaminophen safety. Pharmacoepidemiol Drug Saf. 2016;25(5):599–601. doi:10.1002/pds.3930
   Web of Science ®Google Scholar
• Mazaleuskaya LL, Sangkuhl K, Thorn CF, FitzGerald GA, Altman RB, Klein TE. PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses. Pharmacogenet Genomics. 2015;25(8):416–426. doi:10.1097/FPC.0000000000000150
   PubMed Web of Science ®Google Scholar
• Krenzelok EP, Royal MA. Confusion: acetaminophen dosing changes based on NO evidence in adults. Drugs R D. 2012;12(2):45–48. doi:10.2165/11633010-000000000-00000
   PubMedGoogle Scholar
• Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: the slone survey. JAMA. 2002;287(3):337–344. doi:10.1001/jama.287.3.337
   PubMed Web of Science ®Google Scholar
• Toussaint K, Yang XC, Zielinski MA, et al. What do we (not) know about how paracetamol (acetaminophen) works? J Clin Pharm Ther. 2010;35(6):617–638. doi:10.1111/j.1365-2710.2009.01143.x
   PubMed Web of Science ®Google Scholar
• Holmer Pettersson P, Jakobsson J, Owall A. Plasma concentrations following repeated rectal or intravenous administration of paracetamol after heart surgery. Acta Anaesthesiol Scand. 2006;50(6):673–677. doi:10.1111/j.1399-6576.2006.01043.x
   Web of Science ®Google Scholar
• Holmer Pettersson P, Owall A, Jakobsson J. Early bioavailability of paracetamol after oral or intravenous administration. Acta Anaesthesiol Scand. 2004;48(7):867–870. doi:10.1111/j.0001-5172.2004.00452.x
   Web of Science ®Google Scholar
• Singla NK, Parulan C, Samson R, et al. Plasma and cerebrospinal fluid pharmacokinetic parameters after single-dose administration of intravenous, oral, or rectal acetaminophen. Pain Pract. 2012;12(7):523–532. doi:10.1111/j.1533-2500.2012.00556.x
   PubMed Web of Science ®Google Scholar
• Filitz J, Ihmsen H, Gunther W, et al. Supra-additive effects of tramadol and acetaminophen in a human pain model. Pain. 2008;136(3):262–270. doi:10.1016/j.pain.2007.06.036
   PubMed Web of Science ®Google Scholar
• Sachs CJ. Oral analgesics for acute nonspecific pain. Am Fam Physician. 2005;71(5):913–918.
   PubMed Web of Science ®Google Scholar
• Jones P, Dalziel SR, Lamdin R, Miles-Chan JL, Frampton C. Oral non-steroidal anti-inflammatory drugs versus other oral analgesic agents for acute soft tissue injury. Cochrane Database Syst Rev. 2015;(7):CD007789. doi:10.1002/14651858.CD007789.pub2
   Web of Science ®Google Scholar
• Chou D, Abalos E, Gyte GM, Gulmezoglu AM. Paracetamol/acetaminophen (single administration) for perineal pain in the early postpartum period. Cochrane Database Syst Rev. 2013;(1):CD008407. doi:10.1002/14651858.CD008407.pub2
   Web of Science ®Google Scholar
• McNicol ED, Tzortzopoulou A, Cepeda MS, Francia MB, Farhat T, Schumann R. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: a systematic review and meta-analysis. Br J Anaesth. 2011;106(6):764–775. doi:10.1093/bja/aer107
   PubMed Web of Science ®Google Scholar
• Stephens G, Derry S, Moore RA. Paracetamol (Acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Database Syst Rev. 2016;6:CD011889. doi:10.1002/14651858.CD011889.pub2
   Web of Science ®Google Scholar
• Apfel C, Jahr JR, Kelly CL, Ang RY, Oderda GM. Effect of i.v. acetaminophen on total hip or knee replacement surgery: a case-matched evaluation of a national patient database. Am J Health Syst Pharm. 2015;72(22):1961–1968. doi:10.2146/ajhp140179
   Web of Science ®Google Scholar
• Machado GC, Maher CG, Ferreira PH, et al. Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials. BMJ. 2015;350:h1225. doi:10.1136/bmj.h1225
   PubMed Web of Science ®Google Scholar
• Pickering G, Kastler A, Macian N, et al. The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial. Drug Des Devel Ther. 2015;9:3853–3862. doi:10.2147/DDDT.S81004
   PubMed Web of Science ®Google Scholar
• Sinatra RS, Jahr JS, Reynolds LW, Viscusi ER, Groudine SB, Payen-Champenois C. Efficacy and safety of single and repeated administration of 1 gram intravenous acetaminophen injection (paracetamol) for pain management after major orthopedic surgery. Anesthesiology. 2005;102(4):822–831. doi:10.1097/00000542-200504000-00019
   PubMed Web of Science ®Google Scholar
• Yu S, Eftekhary N, Wiznia D, et al. Evolution of an opioid sparse pain management program for total knee arthroplasty with the addition of intravenous acetaminophen. J Arthroplasty. 2019;35(1):89–94. doi:10.1016/j.arth.2019.08.013
   Web of Science ®Google Scholar
• Li J, Shi SZ, Wang JS, et al. Efficacy of melanoma patients treated with PD-1 inhibitors: protocol for an overview, and a network meta-analysis of randomized controlled trials. Medicine (Baltimore). 2019;98(27):e16342. doi:10.1097/MD.0000000000016342
   Web of Science ®Google Scholar
• Westrich GH, Birch GA, Muskat AR, et al. Intravenous vs oral acetaminophen as a component of multimodal analgesia after total hip arthroplasty: a randomized, blinded trial. J Arthroplasty. 2019;34(7S):S215–S220. doi:10.1016/j.arth.2019.02.030
   PubMed Web of Science ®Google Scholar
• Van Aken H, Thys L, Veekman L, Buerkle H. Assessing analgesia in single and repeated administrations of propacetamol for postoperative pain: comparison with morphine after dental surgery. Anesth Analg. 2004;98(1):159–165. table of contents. doi:10.1213/01.ANE.0000093312.72011.59
   PubMed Web of Science ®Google Scholar
• Rizkalla N, Zane NR, Prodell JL, et al. Use of intravenous acetaminophen in children for analgesia after spinal fusion surgery: a randomized clinical trial. J Pediatr Pharmacol Ther. 2018;23(5):395–404. doi:10.5863/1551-6776-23.5.395
   PubMedGoogle Scholar
• Wininger SJ, Miller H, Minkowitz HS, et al. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery. Clin Ther. 2010;32(14):2348–2369. doi:10.1016/j.clinthera.2010.12.011
   Web of Science ®Google Scholar
• Lee Y, Yu J, Doumouras AG, et al. Intravenous acetaminophen versus placebo in post-bariatric surgery multimodal pain management: a meta-analysis of randomized controlled trials. Obes Surg. 2019;29(4):1420–1428. doi:10.1007/s11695-019-03732-8
   Web of Science ®Google Scholar
• Faiz HR, Rahimzadeh P, Visnjevac O, Behzadi B, Ghodraty MR, Nader ND. Intravenous acetaminophen is superior to ketamine for postoperative pain after abdominal hysterectomy: results of a prospective, randomized, double-blind, multicenter clinical trial. J Pain Res. 2014;7:65–70. doi:10.2147/JPR.S53234
   PubMed Web of Science ®Google Scholar
• Urman RD, Boing EA, Pham AT, et al. Improved outcomes associated with the use of intravenous acetaminophen for management of acute post-surgical pain in cesarean sections and hysterectomies. J Clin Med Res. 2018;10(6):499–507. doi:10.14740/jocmr3380w
   PubMedGoogle Scholar
• Altenau B, Crisp CC, Devaiah CG, Lambers DS. Randomized controlled trial of intravenous acetaminophen for postcesarean delivery pain control. Am J Obstet Gynecol. 2017;217(3):362e1–362 e6. doi:10.1016/j.ajog.2017.04.030
   Web of Science ®Google Scholar
• Ng QX, Loke W, Yeo WS, Chng KYY, Tan CH. A meta-analysis of the utility of preoperative intravenous paracetamol for post-caesarean analgesia. Medicina (Kaunas). 2019;55(8):424. doi:10.3390/medicina55080424
   Web of Science ®Google Scholar
• Herring BO, Ader S, Maldonado A, Hawkins C, Kearson M, Camejo M. Impact of intravenous acetaminophen on reducing opioid use after hysterectomy. Pharmacotherapy. 2014;34(Suppl 1):27S–33S. doi:10.1002/phar.1513
   Web of Science ®Google Scholar
• Jelacic S, Bollag L, Bowdle A, Rivat C, Cain KC, Richebe P. Intravenous acetaminophen as an adjunct analgesic in cardiac surgery reduces opioid consumption but not opioid-related adverse effects: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2016;30(4):997–1004. doi:10.1053/j.jvca.2016.02.010
   Web of Science ®Google Scholar
• Smith E, Lange J, Moore C, Eid I, Jackson L, Monico J. The role of intravenous acetaminophen in post-operative pain control in head and neck cancer patients. Laryngoscope Investig Otolaryngol. 2019;4(2):250–254. doi:10.1002/lio2.254
   Web of Science ®Google Scholar
• Mont MA, Lovelace B, Pham AT, et al. Intravenous acetaminophen may be associated with reduced odds of 30-day readmission after total knee arthroplasty. J Knee Surg. 2018. doi:10.1055/s-0038-1646927
   Web of Science ®Google Scholar
• Woller SA, Eddinger KA, Corr M, Yaksh TL. An overview of pathways encoding nociception. Clin Exp Rheumatol. 2018;36(1):172.
   Web of Science ®Google Scholar
• Patterson DC, Cagle PJ Jr., Poeran J, et al. Effectiveness of intravenous acetaminophen for postoperative pain management in shoulder arthroplasties: a Population-Based Study. J Orthop Translat. 2019;18:119–127. doi:10.1016/j.jot.2018.09.004
   Web of Science ®Google Scholar
• Wilson SH, Hebbar L. Balancing analgesia and toxicity with postoperative acetaminophen: more studies are still needed. Pain Med. 2019;20(11):2331–2332. doi:10.1093/pm/pnz205
   Web of Science ®Google Scholar
• Stundner O, Poeran J, Ladenhauf HN, et al. Effectiveness of intravenous acetaminophen for postoperative pain management in hip and knee arthroplasties: a Population-Based Study. Reg Anesth Pain Med. 2019;44(5):565–572. doi:10.1136/rapm-2018-100145
   Web of Science ®Google Scholar
• Di Munno O, Sarchi C. Effectiveness of tolmetin in rheumatoid arthritis: evaluation by means of a new method. Methods Find Exp Clin Pharmacol. 1982;4(3):203–206.
   Google Scholar
• Solomon L, Abrams G. Bumadizone calcium in the treatment of rheumatoid arthritis. S Afr Med J. 1977;52(10):391–393.
   PubMed Web of Science ®Google Scholar
• Pesa J, Meyer R, Quock TP, Rattana SK, Mody SH. Opioid utilization patterns among medicare patients with diabetic peripheral neuropathy. Am Health Drug Benefits. 2013;6(4):188–196.
   Google Scholar
• Axelsson B, Borup S. Is there an additive analgesic effect of paracetamol at step 3? A double-blind randomized controlled study. Palliat Med. 2003;17(8):724–725. doi:10.1177/026921630301700816
   PubMed Web of Science ®Google Scholar
• Israel FJ, Parker G, Charles M, Reymond L. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Pain Symptom Manage. 2010;39(3):548–554. doi:10.1016/j.jpainsymman.2009.07.008
   PubMed Web of Science ®Google Scholar
• Saragiotto BT, Machado GC, Ferreira ML, Pinheiro MB, Abdel Shaheed C, Maher CG. Paracetamol for low back pain. Cochrane Database Syst Rev. 2016;6:CD012230. doi:10.1002/14651858.CD012230
   Web of Science ®Google Scholar
• Wiffen PJ, Derry S, Moore RA, et al. Oral paracetamol (acetaminophen) for cancer pain. Cochrane Database Syst Rev. 2017;7:CD012637. doi:10.1002/14651858.CD012637.pub2
   PubMed Web of Science ®Google Scholar
• Qaseem A, Wilt TJ, McLean RM, Forciea MA. Clinical guidelines committee of the American college of p. noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American college of physicians. Ann Intern Med. 2017;166(7):514–530. doi:10.7326/M16-2367
   PubMed Web of Science ®Google Scholar
• Jibril F, Sharaby S, Mohamed A, Wilby KJ. Intravenous versus oral acetaminophen for pain: systematic review of current evidence to support clinical decision-making. Can J Hosp Pharm. 2015;68(3):238–247. doi:10.4212/cjhp.v68i3.1458
   PubMedGoogle Scholar
• McNicol ED, Ferguson MC, Haroutounian S, Carr DB, Schumann R. Single dose intravenous paracetamol or intravenous propacetamol for postoperative pain. Cochrane Database Syst Rev. 2016;5:CD007126. doi:10.1002/14651858.CD007126.pub3
   Web of Science ®Google Scholar
• Mitidieri A, Donati E, Caronzolo N. Injectable supersaturated acetaminophen solution for spinal administration. Available from: https://patents.google.com/patent/DK2874602T3/en. Accessed September 23, 2021.
   Google Scholar
• Sharma CV, Long JH, Shah S, et al. First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid. J Pain Res. 2017;10:2703–2709. doi:10.2147/JPR.S143500
   PubMed Web of Science ®Google Scholar
• Koppert W, Wehrfritz A, Korber N, et al. The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans. Pain. 2004;108(1–2):148–153. doi:10.1016/j.pain.2003.12.017
   Web of Science ®Google Scholar
• Yue Y, Collaku A. Correlation of pain reduction with fMRI BOLD response in osteoarthritis patients treated with paracetamol: Randomized, Double-Blind, Crossover Clinical Efficacy Study. Pain Med. 2018;19(2):355–367. doi:10.1093/pm/pnx157
   Web of Science ®Google Scholar
• Leopoldino AO, Machado GC, Ferreira PH, et al. Paracetamol versus placebo for knee and hip osteoarthritis. Cochrane Database Syst Rev. 2019;2:CD013273. doi:10.1002/14651858.CD013273
   PubMed Web of Science ®Google Scholar
• Hahn TW, Mogensen T, Lund C, et al. Analgesic effect of i.v. paracetamol: possible ceiling effect of paracetamol in postoperative pain. Acta Anaesthesiol Scand. 2003;47(2):138–145. doi:10.1034/j.1399-6576.2003.00046.x
   Web of Science ®Google Scholar
• Montserrat-de La Paz S, Garcia-Gimenez MD, Quilez AM, De la Puerta R, Fernandez-Arche A. Ginger rhizome enhances the anti-inflammatory and anti-nociceptive effects of paracetamol in an experimental mouse model of fibromyalgia. Inflammopharmacology. 2018;26(4):1093–1101. doi:10.1007/s10787-018-0450-8
   PubMed Web of Science ®Google Scholar
• Klinger-Gratz PP, Ralvenius WT, Neumann E, et al. Acetaminophen relieves inflammatory pain through CB1 cannabinoid receptors in the rostral ventromedial medulla. J Neurosci. 2018;38(2):322–334. doi:10.1523/JNEUROSCI.1945-17.2017
   PubMed Web of Science ®Google Scholar
• Bhagyashree A, Manikkoth S, Sequeira M, Nayak R, Rao SN. Central dopaminergic system plays a role in the analgesic action of paracetamol: preclinical evidence. Indian J Pharmacol. 2017;49(1):21–25. doi:10.4103/0253-7613.201029
   Web of Science ®Google Scholar
• Zhu Q, Sun Y, Mao L, et al. Antinociceptive effects of sinomenine in a rat model of postoperative pain. Br J Pharmacol. 2016;173(10):1693–1702. doi:10.1111/bph.13470
   Web of Science ®Google Scholar
• Kerckhove N, Mallet C, Francois A, et al. Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol. Pain. 2014;155(4):764–772. doi:10.1016/j.pain.2014.01.015
   PubMed Web of Science ®Google Scholar
• Vijayakaran K, Kesavan M, Kannan K, Sankar P, Tandan SK, Sarkar SN. Arsenic decreases antinociceptive activity of paracetamol: possible involvement of serotonergic and endocannabinoid receptors. Environ Toxicol Pharmacol. 2014;38(2):397–405. doi:10.1016/j.etap.2014.07.001
   Web of Science ®Google Scholar
• Dogrul A, Seyrek M, Akgul EO, Cayci T, Kahraman S, Bolay H. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT(7) receptors. Eur J Pharmacol. 2012;677(1–3):93–101. doi:10.1016/j.ejphar.2011.12.016
   PubMed Web of Science ®Google Scholar
• Mallet C, Barriere DA, Ermund A, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One. 2010;5(9):e12748. doi:10.1371/journal.pone.0012748
   PubMed Web of Science ®Google Scholar
• Crawley B, Saito O, Malkmus S, Fitzsimmons B, Hua XY, Yaksh TL. Acetaminophen prevents hyperalgesia in central pain cascade. Neurosci Lett. 2008;442(1):50–53. doi:10.1016/j.neulet.2008.06.062
   Web of Science ®Google Scholar
• Joshi SK, Mikusa JP, Weaver B, Honore P. Morphine and ABT-594 (a nicotinic acetylcholine agonist) exert centrally mediated antinociception in the rat cyclophosphamide cystitis model of visceral pain. J Pain. 2008;9(2):146–156. doi:10.1016/j.jpain.2007.09.004
   Web of Science ®Google Scholar
• Ruggieri V, Vitale G, Pini LA, Sandrini M. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol. 2008;377(3):219–229. doi:10.1007/s00210-008-0284-9
   PubMed Web of Science ®Google Scholar
• Ottani A, Leone S, Sandrini M, Ferrari A, Bertolini A. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol. 2006;531(1–3):280–281. doi:10.1016/j.ejphar.2005.12.015
   PubMed Web of Science ®Google Scholar
• Saito O, Aoe T, Yamamoto T. Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain. J Anesth. 2005;19(3):218–224. doi:10.1007/s00540-005-0323-3
   Google Scholar
• Kwon MS, Shim EJ, Seo YJ, et al. Effect of aspirin and acetaminophen on proinflammatory cytokine-induced pain behavior in mice. Pharmacology. 2005;74(3):152–156. doi:10.1159/000084548
   PubMed Web of Science ®Google Scholar
• Lynch JJ 3rd, Wade CL, Zhong CM, Mikusa JP, Honore P. Attenuation of mechanical allodynia by clinically utilized drugs in a rat chemotherapy-induced neuropathic pain model. Pain. 2004;110(1–2):56–63. doi:10.1016/j.pain.2004.03.010
   PubMed Web of Science ®Google Scholar
• Bujalska M. Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of acetaminophen [part III]. Pol J Pharmacol. 2004;56(5):539–545.
   Google Scholar
• Bonnefont J, Alloui A, Chapuy E, Clottes E, Eschalier A. Orally administered paracetamol does not act locally in the rat formalin test: evidence for a supraspinal, serotonin-dependent antinociceptive mechanism. Anesthesiology. 2003;99(4):976–981. doi:10.1097/00000542-200310000-00034
   PubMed Web of Science ®Google Scholar
• Nagakura Y, Okada M, Kohara A, et al. Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics. J Pharmacol Exp Ther. 2003;306(2):490–497. doi:10.1124/jpet.103.050781
   Web of Science ®Google Scholar
• Bujalska M, Gumulka WS. Effect of cyclooxygenase and NO synthase inhibitors on antinociceptive action of acetaminophen. Pol J Pharmacol. 2001;53(4):341–350.
   Google Scholar
• Choi SS, Lee JK, Suh HW. Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res. 2001;921(1–2):233–239. doi:10.1016/S0006-8993(01)03126-2
   PubMed Web of Science ®Google Scholar
• Al-Swayeh OA, Futter LE, Clifford RH, Moore PK. Nitroparacetamol exhibits anti-inflammatory and anti-nociceptive activity. Br J Pharmacol. 2000;130(7):1453–1456. doi:10.1038/sj.bjp.0703509
   Web of Science ®Google Scholar
• Pelissier T, Alloui A, Caussade F, et al. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3 receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther. 1996;278(1):8–14.
   Web of Science ®Google Scholar
• Granados-Soto V, Flores-Murrieta FJ, Lopez-Munoz FJ, Salazar LA, Villarreal JE, Castaneda-Hernandez G. Relationship between paracetamol plasma levels and its analgesic effect in the rat. J Pharm Pharmacol. 1992;44(9):741–744. doi:10.1111/j.2042-7158.1992.tb05511.x
   Web of Science ®Google Scholar
• Okuyama S, Aihara H. The mode of action of analgesic drugs in adjuvant arthritic rats as an experimental model of chronic inflammatory pain: possible central analgesic action of acidic nonsteroidal antiinflammatory drugs. Jpn J Pharmacol. 1984;35(2):95–103. doi:10.1016/S0021-5198(19)38076-X
   Google Scholar
• Dalmann R, Daulhac L, Antri M, Eschalier A, Mallet C. Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context. Neuropharmacology. 2015;91:63–70. doi:10.1016/j.neuropharm.2014.11.006
   Web of Science ®Google Scholar
• Viberg H, Eriksson P, Gordh T, Fredriksson A. Paracetamol (acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice. Toxicol Sci. 2014;138(1):139–147. doi:10.1093/toxsci/kft329
   PubMed Web of Science ®Google Scholar
• Aizawa N, Wyndaele JJ. Effects of phenazopyridine on rat bladder primary afferent activity, and comparison with lidocaine and acetaminophen. Neurourol Urodyn. 2010;29(8):1445–1450. doi:10.1002/nau.20886
   Web of Science ®Google Scholar
• Soukupova M, Dolezal T, Krsiak M. The synergistic interaction between rilmenidine and paracetamol in the writhing test in mice. Naunyn Schmiedebergs Arch Pharmacol. 2009;379(6):575–580. doi:10.1007/s00210-009-0402-3
   Web of Science ®Google Scholar
• Qiu HX, Liu J, Kong H, Liu Y, Mei XG. Isobolographic analysis of the antinociceptive interactions between ketoprofen and paracetamol. Eur J Pharmacol. 2007;557(2–3):141–146. doi:10.1016/j.ejphar.2006.11.017
   Web of Science ®Google Scholar
• Mallet C, Daulhac L, Bonnefont J, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain. 2008;139(1):190–200. doi:10.1016/j.pain.2008.03.030
   PubMed Web of Science ®Google Scholar
• Bianchi M, Panerai AE. The dose-related effects of paracetamol on hyperalgesia and nociception in the rat. Br J Pharmacol. 1996;117(1):130–132. doi:10.1111/j.1476-5381.1996.tb15164.x
   Web of Science ®Google Scholar
• Mburu DN. Evaluation of the anti-inflammatory effects of a low dose of acetaminophen following surgery in dogs. J Vet Pharmacol Ther. 1991;14(1):109–111. doi:10.1111/j.1365-2885.1991.tb00811.x
   Web of Science ®Google Scholar
• Behrendt WA, Cserepes J. Acute toxicity and analgesic action of a combination of buclizine, codeine and paracetamol (‘Migraleve’) in tablet and suppository form in rats. Pharmatherapeutica. 1985;4(5):322–331.
   Google Scholar
• Sewell RD, Gonzalez JP, Pugh J. Comparison of the relative effects of aspirin, mefenamic acid, dihydrocodeine, dextropropoxyphene and paracetamol on visceral pain, respiratory rate and prostaglandin biosynthesis. Arch Int Pharmacodyn Ther. 1984;268(2):325–334.
   Google Scholar
• Pircio AW, Buyniski JP, Roebel LE. Pharmacological effects of a combination of butorphanol and acetaminophen. Arch Int Pharmacodyn Ther. 1978;235(1):116–123.
   PubMedGoogle Scholar
• Mititelu Tartau L, Popa EG, Lupusoru RV, Lupusoru CE, Stoleriu I, Ochiuz L. Synergic effects of pregabalin-acetaminophen combination in somatic and visceral nociceptive reactivity. Pharmacology. 2014;93(5–6):253–259. doi:10.1159/000362649
   PubMed Web of Science ®Google Scholar
• Vinegar R, Truax JF, Selph JL. Quantitative comparison of the analgesic and anti-inflammatory activities of aspirin, phenacetin and acetaminophen in rodents. Eur J Pharmacol. 1976;37(1):23–30. doi:10.1016/0014-2999(76)90004-2
   Web of Science ®Google Scholar
• Micov A, Tomic M, Pecikoza U, Ugresic N, Stepanovic-Petrovic R. Levetiracetam synergises with common analgesics in producing antinociception in a mouse model of painful diabetic neuropathy. Pharmacol Res. 2015;97:131–142. doi:10.1016/j.phrs.2015.04.014
   Web of Science ®Google Scholar
• Shinozaki T, Yamada T, Nonaka T, Yamamoto T. Acetaminophen and non-steroidal anti-inflammatory drugs interact with morphine and tramadol analgesia for the treatment of neuropathic pain in rats. J Anesth. 2015;29(3):386–395. doi:10.1007/s00540-014-1953-0
   PubMed Web of Science ®Google Scholar
• Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240(5381):410–411. doi:10.1038/240410a0
   PubMed Web of Science ®Google Scholar
• Zapata-Morales JR, Alonso-Castro AJ, Perez-Gutierrez S, et al. Participation of ATP-sensitive K+ channels and mu-opioid receptors in the antinociceptive synergism of the paracetamol-tapentadol co-administration in the formalin-induced pain assay in mice. Drug Dev Res. 2018;79(8):400–405. doi:10.1002/ddr.21476
   Web of Science ®Google Scholar
• Li Q, Zhuang Q, Gu Y, et al. Enhanced analgesic effects of nefopam in combination with acetaminophen in rodents. Biomed Rep. 2018;8(2):176–183. doi:10.3892/br.2017.1032
   Web of Science ®Google Scholar
• Fukushima A, Mamada K, Iimura A, Ono H. Supraspinal-selective TRPV1 desensitization induced by intracerebroventricular treatment with resiniferatoxin. Sci Rep. 2017;7(1):12452. doi:10.1038/s41598-017-12717-5
   Web of Science ®Google Scholar
• Siemian JN, Li J, Zhang Y, Li JX. Interactions between imidazoline I2 receptor ligands and acetaminophen in adult male rats: antinociception and schedule-controlled responding. Psychopharmacology (Berl). 2016;233(5):873–882. doi:10.1007/s00213-015-4166-9
   Web of Science ®Google Scholar
• Karandikar YS, Belsare P, Panditrao A. Effect of drugs modulating serotonergic system on the analgesic action of paracetamol in mice. Indian J Pharmacol. 2016;48(3):281–285. doi:10.4103/0253-7613.182874
   Web of Science ®Google Scholar
• Raskovic A, Milanovic I, Pavlovic N, Milijasevic B, Ubavic M, Mikov M. Analgesic effects of rosemary essential oil and its interactions with codeine and paracetamol in mice. Eur Rev Med Pharmacol Sci. 2015;19(1):165–172.
   PubMed Web of Science ®Google Scholar
• Fresno N, Perez-Fernandez R, Goicoechea C, et al. Adamantyl analogues of paracetamol as potent analgesic drugs via inhibition of TRPA1. PLoS One. 2014;9(12):e113841. doi:10.1371/journal.pone.0113841
   PubMed Web of Science ®Google Scholar
• Minville V, Fourcade O, Mazoit JX, Girolami JP, Tack I. Ondansetron does not block paracetamol-induced analgesia in a mouse model of fracture pain. Br J Anaesth. 2011;106(1):112–118. doi:10.1093/bja/aeq277
   Web of Science ®Google Scholar
• Tomic MA, Vuckovic SM, Stepanovic-Petrovic RM, Ugresic ND, Prostran MS, Boskovic B. Synergistic interactions between paracetamol and oxcarbazepine in somatic and visceral pain models in rodents. Anesth Analg. 2010;110(4):1198–1205. doi:10.1213/ANE.0b013e3181cbd8da
   Web of Science ®Google Scholar
• Mitchell D, Gelgor L, Weber J, Kamerman PR. Antihypernociceptive synergy between ibuprofen, paracetamol and codeine in rats. Eur J Pharmacol. 2010;642(1–3):86–92. doi:10.1016/j.ejphar.2010.06.004
   Web of Science ®Google Scholar
• Godfrey L, Yan L, Clarke GD, Ledent C, Kitchen I, Hourani SM. Modulation of paracetamol antinociception by caffeine and by selective adenosine A2 receptor antagonists in mice. Eur J Pharmacol. 2006;531(1–3):80–86. doi:10.1016/j.ejphar.2005.12.004
   PubMed Web of Science ®Google Scholar
• Sandrini M, Pini LA, Vitale G. Differential involvement of central 5-HT1B and 5-HT3 receptor subtypes in the antinociceptive effect of paracetamol. Inflamm Res. 2003;52(8):347–352. doi:10.1007/s00011-003-1185-5
   Web of Science ®Google Scholar
• Sandrini M, Vitale G, Ottani A, Pini LA. The potentiation of analgesic activity of paracetamol plus morphine involves the serotonergic system in rat brain. Inflamm Res. 1999;48(3):120–127. doi:10.1007/s000110050434
   Web of Science ®Google Scholar
• Tjolsen A, Lund A, Hole K. The role of descending noradrenergic systems in regulation of nociception: the effects of intrathecally administered alpha-adrenoceptor antagonists and clonidine. Pain. 1990;43(1):113–120. doi:10.1016/0304-3959(90)90056-J
   Web of Science ®Google Scholar
• Liu J, Reid AR, Sawynok J. Antinociception by systemically-administered acetaminophen (paracetamol) involves spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors. Neurosci Lett. 2013;536:64–68. doi:10.1016/j.neulet.2012.12.052
   PubMed Web of Science ®Google Scholar
• Miranda HF, Noriega V, Prieto JC. Previous administration of naltrexone did not change synergism between paracetamol and tramadol in mice. Pharmacol Biochem Behav. 2012;102(1):72–76. doi:10.1016/j.pbb.2012.03.008
   Web of Science ®Google Scholar
• Im KS, Jung HJ, Kim JB, et al. The antinociceptive effect of acetaminophen in a rat model of neuropathic pain. Kaohsiung J Med Sci. 2012;28(5):251–258. doi:10.1016/j.kjms.2011.11.003
   Web of Science ®Google Scholar
• Sawynok J, Reid AR. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A(1) receptors. Eur J Pharmacol. 2012;674(2–3):248–254. doi:10.1016/j.ejphar.2011.10.036
   PubMed Web of Science ®Google Scholar
• Rezende RM, Franca DS, Menezes GB, dos Reis WGP, Bakhle YS, Francischi JN. Different mechanisms underlie the analgesic actions of paracetamol and dipyrone in a rat model of inflammatory pain. Br J Pharmacol. 2008;153(4):760–768. doi:10.1038/sj.bjp.0707630
   Web of Science ®Google Scholar
• Luccarini P, Childeric A, Gaydier AM, Voisin D, Dallel R. The orofacial formalin test in the mouse: a behavioral model for studying physiology and modulation of trigeminal nociception. J Pain. 2006;7(12):908–914. doi:10.1016/j.jpain.2006.04.010
   Web of Science ®Google Scholar
• Abbott FV, Hellemans KG. Phenacetin, acetaminophen and dipyrone: analgesic and rewarding effects. Behav Brain Res. 2000;112(1–2):177–186. doi:10.1016/S0166-4328(00)00179-0
   Web of Science ®Google Scholar
• Srikiatkhachorn A, Tarasub N, Govitrapong P. Acetaminophen-induced antinociception via central 5-HT(2A) receptors. Neurochem Int. 1999;34(6):491–498. doi:10.1016/S0197-0186(99)00023-6
   PubMed Web of Science ®Google Scholar
• Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol. 1996;308(1):31–40. doi:10.1016/0014-2999(96)00261-0
   PubMed Web of Science ®Google Scholar
• Bjorkman R. Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat. Acta Anaesthesiol Scand Suppl. 1995;103:1–44.
   PubMedGoogle Scholar
• Bjorkman R, Hallman KM, Hedner J, Hedner T, Henning M. Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P. Pain. 1994;57(3):259–264. doi:10.1016/0304-3959(94)90001-9
   PubMed Web of Science ®Google Scholar
• Kanui TI, Karim F, Towett PK. The formalin test in the naked mole-rat (heterocephalus glaber): analgesic effects of morphine, nefopam and paracetamol. Brain Res. 1993;600(1):123–126. doi:10.1016/0006-8993(93)90409-g
   Web of Science ®Google Scholar
• Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther. 1992;263(1):136–146.
   Web of Science ®Google Scholar
• Tjolsen A, Lund A, Hole K. Antinociceptive effect of paracetamol in rats is partly dependent on spinal serotonergic systems. Eur J Pharmacol. 1991;193(2):193–201. doi:10.1016/0014-2999(91)90036-P
   PubMed Web of Science ®Google Scholar
• Carlsson KH, Jurna I. Central analgesic effect of paracetamol manifested by depression of nociceptive activity in thalamic neurones of the rat. Neurosci Lett. 1987;77(3):339–343. doi:10.1016/0304-3940(87)90524-6
   Web of Science ®Google Scholar
• Ferreira SH, Lorenzetti BB, Correa FM. Central and peripheral antialgesic action of aspirin-like drugs. Eur J Pharmacol. 1978;53(1):39–48. doi:10.1016/0014-2999(78)90265-0
   PubMed Web of Science ®Google Scholar
• Hunskaar S, Fasmer OB, Hole K. Acetylsalicylic acid, paracetamol and morphine inhibit behavioral responses to intrathecally administered substance P or capsaicin. Life Sci. 1985;37(19):1835–1841. doi:10.1016/0024-3205(85)90227-9
   Web of Science ®Google Scholar
• Hama AT, Sagen J. Cannabinoid receptor-mediated antinociception with Acetaminophen drug combinations in rats with neuropathic spinal cord injury pain. Neuropharmacology. 2010;58(4–5):758–766. doi:10.1016/j.neuropharm.2009.12.010
   PubMed Web of Science ®Google Scholar
• Munro G, Christensen JK, Erichsen HK, et al. NS383 selectively inhibits acid-sensing ion channels containing 1a and 3 subunits to reverse inflammatory and neuropathic hyperalgesia in rats. CNS Neurosci Ther. 2016;22(2):135–145. doi:10.1111/cns.12487
   PubMed Web of Science ®Google Scholar
• Sandrini M, Vitale G, Ruggieri V, Pini LA. Effect of acute and repeated administration of paracetamol on opioidergic and serotonergic systems in rats. Inflamm Res. 2007;56(4):139–142. doi:10.1007/s00011-006-6113-z
   PubMed Web of Science ®Google Scholar
• Roca-Vinardell A, Ortega-Alvaro A, Gibert-Rahola J, Mico JA. The role of 5-HT1A/B autoreceptors in the antinociceptive effect of systemic administration of acetaminophen. Anesthesiology. 2003;98(3):741–747. doi:10.1097/00000542-200303000-00025
   Web of Science ®Google Scholar
• Andersson DA, Gentry C, Alenmyr L, et al. TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid delta(9)-tetrahydrocannabiorcol. Nat Commun. 2011;2(1):551. doi:10.1038/ncomms1559
   PubMed Web of Science ®Google Scholar
• Cui JG, Zhang X, Zhao YH, Chen C, Bazan N. Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain. Biochem Biophys Res Commun. 2006;350(2):358–363. doi:10.1016/j.bbrc.2006.09.055
   Web of Science ®Google Scholar
• Alloui A, Chassaing C, Schmidt J, et al. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol. 2002;443(1–3):71–77. doi:10.1016/S0014-2999(02)01578-9
   PubMed Web of Science ®Google Scholar
• Raffa RB, Stone DJ Jr., Tallarida RJ. Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine. Eur J Pharmacol. 2001;412(2):R1–2. doi:10.1016/S0014-2999(01)00722-1
   Web of Science ®Google Scholar
• Jensen FM, Dahl JB, Frigast C. Direct spinal effect of intrathecal acetaminophen on visceral noxious stimulation in rabbits. Acta Anaesthesiol Scand. 1992;36(8):837–841. doi:10.1111/j.1399-6576.1992.tb03574.x
   Web of Science ®Google Scholar
• Seo YJ, Kwon MS, Choi HW, et al. The differential effects of acetaminophen on lipopolysaccharide induced hyperalgesia in various mouse pain models. Pharmacol Biochem Behav. 2008;91(1):121–127. doi:10.1016/j.pbb.2008.06.020
   Web of Science ®Google Scholar
• Matsunaga A, Kawamoto M, Shiraishi S, et al. Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats. Eur J Pharmacol. 2007;554(1):12–17. doi:10.1016/j.ejphar.2006.09.072
   Web of Science ®Google Scholar
• Curros-Criado MM, Herrero JF. Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: enhancement of antinociception by co-administration with gabapentin. Br J Pharmacol. 2009;158(2):601–609. doi:10.1111/j.1476-5381.2009.00343.x
   Web of Science ®Google Scholar
• Bonnefont J, Chapuy E, Clottes E, Alloui A, Eschalier A. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain. 2005;114(3):482–490. doi:10.1016/j.pain.2005.01.019
   PubMed Web of Science ®Google Scholar
• Romero-Sandoval EA, Mazario J, Howat D, Herrero JF. NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up. Br J Pharmacol. 2002;135(6):1556–1562. doi:10.1038/sj.bjp.0704589
   PubMed Web of Science ®Google Scholar
• Courade JP, Chassaing C, Bardin L, Alloui A, Eschalier A. 5-HT receptor subtypes involved in the spinal antinociceptive effect of Acetaminophen in rats. Eur J Pharmacol. 2001;432(1):1–7. doi:10.1016/S0014-2999(01)01464-9
   Web of Science ®Google Scholar
• Shibasaki J, Konishi R, Kitasaki T, Koizumi T. Relationship between blood levels and analgesic effects of acetaminophen in mice. Chem Pharm Bull (Tokyo). 1979;27(1):129–138. doi:10.1248/cpb.27.129
   Web of Science ®Google Scholar
• Pelissier T, Alloui A, Paeile C, Eschalier A. Evidence of a central antinociceptive effect of paracetamol involving spinal 5HT3 receptors. Neuroreport. 1995;6(11):1546–1548. doi:10.1097/00001756-199507310-00020
   PubMed Web of Science ®Google Scholar
• Raffa RB, Stone DJ Jr., Tallarida RJ. Discovery of “self-synergistic” spinal/supraspinal antinociception produced by acetaminophen (paracetamol). J Pharmacol Exp Ther. 2000;295(1):291–294.
   Web of Science ®Google Scholar
• Dani M, Guindon J, Lambert C, Beaulieu P. The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors. Eur J Pharmacol. 2007;573(1–3):214–215. doi:10.1016/j.ejphar.2007.07.012
   PubMed Web of Science ®Google Scholar
• Deciga-Campos M, Ortiz-Andrade R. Enhancement of antihyperalgesia by the coadministration of N-palmitoylethanolamide and acetaminophen in diabetic rats. Drug Dev Res. 2015;76(5):228–234. doi:10.1002/ddr.21259
   Web of Science ®Google Scholar
• Gonzalez-Trujano ME, Uribe-Figueroa G, Hidalgo-Figueroa S, Martinez AL, Deciga-Campos M, Navarrete-Vazquez G. Synthesis and antinociceptive evaluation of bioisosteres and hybrids of naproxen, ibuprofen and paracetamol. Biomed Pharmacother. 2018;101:553–562. doi:10.1016/j.biopha.2018.02.122
   PubMed Web of Science ®Google Scholar
• Lopez-Canul M, Comai S, Dominguez-Lopez S, Granados-Soto V, Gobbi G. Antinociceptive properties of selective MT(2) melatonin receptor partial agonists. Eur J Pharmacol. 2015;764:424–432. doi:10.1016/j.ejphar.2015.07.010
   PubMed Web of Science ®Google Scholar
• Girard P, Niedergang B, Pansart Y, Coppe MC, Verleye M. Systematic evaluation of the nefopam-paracetamol combination in rodent models of antinociception. Clin Exp Pharmacol Physiol. 2011;38(3):170–178. doi:10.1111/j.1440-1681.2011.05477.x
   Web of Science ®Google Scholar
• Wong CL, Wai MK, Roberts MB. The effect of aspirin and paracetamol on the increased naloxone potency induced by morphine pretreatment. Eur J Pharmacol. 1980;67(2–3):241–246. doi:10.1016/0014-2999(80)90504-x
   Web of Science ®Google Scholar
• Girard P, Pansart Y, Coppe MC, Niedergang B, Gillardin JM. Modulation of paracetamol and nefopam antinociception by serotonin 5-HT(3) receptor antagonists in mice. Pharmacology. 2009;83(4):243–246. doi:10.1159/000207448
   Web of Science ®Google Scholar
• O’Neil MJ. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. Royal Society of Chemistry; 2013.
   Google Scholar
• Samuel H, He Y, Jain P. Handbook of Aqueous Solubility Data Second Edition. CRC Press; 2010:492.
   Google Scholar
• Kalatzis E. Reactions of acetaminophen in pharmaceutical dosage forms: its proposed acetylation by acetylsalicylic acid. J Pharm Sci. 1970;59(2):193–196. doi:10.1002/jps.2600590211
   Web of Science ®Google Scholar
• Gilpin RK, Zhou W. Studies of the thermal degradation of acetaminophen using a conventional HPLC approach and electrospray ionization-mass spectrometry. J Chromatogr Sci. 2004;42(1):15–20. doi:10.1093/chromsci/42.1.15
   Web of Science ®Google Scholar
• Fairbrother JE. Analytical Profiles of Drug Substances. Vol. 3. Acetominophen. Academic Press; 1974:1–110.
   Google Scholar
• Kelava T, Cavar I, Culo F. Influence of small doses of various drug vehicles on acetaminophen-induced liver injury. Can J Physiol Pharmacol. 2010;88(10):960–967. doi:10.1139/y10-065
   PubMed Web of Science ®Google Scholar
• D’Amour F, Smith D. A method for determining loss of pain sensation. J Pharmacol Exp Ther. 1941;72:74–79.
   Google Scholar
• Woolfe G, MacDonald A. The evaluation of the analgesic action of pethidine hydrochloride (demerol). J Pharmacol Exp Ther. 1944;80:300–307.
   Google Scholar
• Dirig DM, Salami A, Rathbun ML, Ozaki GT, Yaksh TL. Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods. 1997;76(2):183–191. doi:10.1016/s0165-0270(97)00097-6
   Web of Science ®Google Scholar
• Barrot M. Tests and models of nociception and pain in rodents. Neuroscience. 2012;211:39–50. doi:10.1016/j.neuroscience.2011.12.041
   PubMed Web of Science ®Google Scholar
• Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957;111(4):409–419.
   PubMedGoogle Scholar
• Libert F, Bonnefont J, Bourinet E, et al. Acetaminophen: a central analgesic drug that involves a spinal tropisetron-sensitive, non-5-HT(3) receptor-mediated effect. Mol Pharmacol. 2004;66(3):728–734. doi:10.1124/mol.66.3
   Web of Science ®Google Scholar
• Carlsson KH, Monzel W, Jurna I. Depression by morphine and the non-opioid analgesic agents, metamizol (dipyrone), lysine acetylsalicylate, and paracetamol, of activity in rat thalamus neurones evoked by electrical stimulation of nociceptive afferents. Pain. 1988;32(3):313–326. doi:10.1016/0304-3959(88)90043-7
   Web of Science ®Google Scholar
• Davidson N, Southwick CA. The effect of topically applied amino acids on primary afferent terminal excitability in the rat cuneate nucleus. J Physiol. 1970;210(2):172P–173P.
   Web of Science ®Google Scholar
• Hokfelt T, Kellerth JO, Nilsson G, Pernow B. Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 1975;100(2):235–252. doi:10.1016/0006-8993(75)90481-3
   Web of Science ®Google Scholar
• Woller SA, Eddinger KA, Corr M, Yaksh TL. An overview of pathways encoding nociception. Clin Exp Rheumatol. 2017;107(5):40–46.
   Google Scholar
• Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain. 1996;64(3):493–501. doi:10.1016/0304-3959(95)01441-1
   PubMed Web of Science ®Google Scholar
• Yaksh TL, Ozaki G, McCumber D, et al. An automated flinch detecting system for use in the formalin nociceptive bioassay. J Appl Physiol. 2001;90(6):2386–2402. doi:10.1152/jappl.2001.90.6.2386
   PubMed Web of Science ®Google Scholar
• Regmi B, Shah MK. Possible implications of animal models for the assessment of visceral pain. Animal Model Exp Med. 2020;3(3):215–228. doi:10.1002/ame2.12130
   Google Scholar
• Greenwood-van Meerveld B, Prusator DK, Johnson AC. Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges. Am J Physiol Gastrointest Liver Physiol. 2015;308(11):G885–903. doi:10.1152/ajpgi.00463.2014
   Web of Science ®Google Scholar
• Birder L, Andersson KE. Animal modelling of interstitial cystitis/bladder pain syndrome. Int Neurourol J. 2018;22(Suppl 1):S3–9. doi:10.5213/inj.1835062.531
   PubMed Web of Science ®Google Scholar
• Simmons JK, Hildreth BE 3rd, Supsavhad W, et al. Animal models of bone metastasis. Vet Pathol. 2015;52(5):827–841. doi:10.1177/0300985815586223
   Web of Science ®Google Scholar
• Jimenez-Andrade JM, Mantyh WG, Bloom AP, Ferng AS, Geffre CP, Mantyh PW. Bone cancer pain. Ann N Y Acad Sci. 2010;1198(1):173–181. doi:10.1111/j.1749-6632.2009.05429.x
   PubMed Web of Science ®Google Scholar
• Sorkin LS, Yaksh TL. Behavioral models of pain states evoked by physical injury to the peripheral nerve. Neurotherapeutics. 2009;6(4):609–619. doi:10.1016/j.nurt.2009.07.007
   PubMed Web of Science ®Google Scholar
• Grothey A. Clinical management of oxaliplatin-associated neurotoxicity. Clin Colorectal Cancer. 2005;5(Suppl 1):S38–46. doi:10.3816/CCC.2005.s.006
   Google Scholar
• Lee-Kubli CA, Calcutt NA. Painful neuropathy: mechanisms. Handb Clin Neurol. 2014;126:533–557. doi:10.1016/B978-0-444-53480-4.00034-5
   PubMedGoogle Scholar
• Lee-Kubli C, Marshall AG, Malik RA, Calcutt NA. The H-reflex as a biomarker for spinal disinhibition in painful diabetic neuropathy. Curr Diab Rep. 2018;18(1):1. doi:10.1007/s11892-018-0969-5
   PubMed Web of Science ®Google Scholar
• Apostolidis L, Schwarz D, Xia A, et al. Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy. PLoS One. 2017;12(8):e0183845. doi:10.1371/journal.pone.0183845
   PubMed Web of Science ®Google Scholar
• Chaturvedi PR, Decker CJ, Odinecs A. Prediction of pharmacokinetic properties using experimental approaches during early drug discovery. Curr Opin Chem Biol. 2001;5(4):452–463. doi:10.1016/s1367-5931(00)00228-3
   PubMed Web of Science ®Google Scholar
• Rhomberg L, Lewandowski T. Methods for identifying a default cross-species scaling factor. Hum Ecol Risk Assess. 2006;12(6):1094–1127. doi:10.1080/10807030600977269
   Web of Science ®Google Scholar
• Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27–31. doi:10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Cummings AJ, King ML, Martin BK. A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967;29(2):150–157. doi:10.1111/j.1476-5381.1967.tb01948.x
   Web of Science ®Google Scholar
• Galinsky RE, Levy G. Dose- and time-dependent elimination of acetaminophen in rats: pharmacokinetic implications of cosubstrate depletion. J Pharmacol Exp Ther. 1981;219(1):14–20.
   Web of Science ®Google Scholar
• McGill MR, Jaeschke H. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharm Res. 2013;30(9):2174–2187. doi:10.1007/s11095-013-1007-6
   PubMed Web of Science ®Google Scholar
• Hogestatt ED, Jonsson BA, Ermund A, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005;280(36):31405–31412. doi:10.1074/jbc.M501489200
   PubMed Web of Science ®Google Scholar
• Woolbright BL, Jaeschke H. Role of the inflammasome in Acetaminophen-induced liver injury and acute liver failure. J Hepatol. 2017;66(4):836–848. doi:10.1016/j.jhep.2016.11.017
   PubMed Web of Science ®Google Scholar
• Athersuch TJ, Antoine DJ, Boobis AR, et al. Paracetamol metabolism, hepatotoxicity, biomarkers and therapeutic interventions: a perspective. Toxicol Res (Camb). 2018;7(3):347–357. doi:10.1039/c7tx00340d
   Web of Science ®Google Scholar
• Courad JP, Besse D, Delchambre C, et al. Acetaminophen distribution in the rat central nervous system. Life Sci. 2001;69(12):1455–1464. doi:10.1016/s0024-3205(01)01228-0
   Web of Science ®Google Scholar
• Godfrey L, Morselli A, Bennion P, Clarke GD, Hourani SM, Kitchen I. An investigation of binding sites for paracetamol in the mouse brain and spinal cord. Eur J Pharmacol. 2005;508(1–3):99–106. doi:10.1016/j.ejphar.2004.11.061
   Web of Science ®Google Scholar
• Raffa RB, Codd EE. Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays). Life Sci. 1996;59(2):PL37–40. doi:10.1016/0024-3205(96)00273-1
   Web of Science ®Google Scholar
• Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol. 2002;42:553–583. doi:10.1146/annurev.pharmtox.42.092401.143905
   PubMed Web of Science ®Google Scholar
• Patrignani P, Patrono C. Cyclooxygenase inhibitors: from pharmacology to clinical read-outs. Biochim Biophys Acta. 2015;1851(4):422–432. doi:10.1016/j.bbalip.2014.09.016
   PubMed Web of Science ®Google Scholar
• Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. FASEB J. 2005;19(6):635–637. doi:10.1096/fj.04-2437fje
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Colville-Nash PR, Willoughby DA, Botting RM. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol. 2006;538(1–3):57–65. doi:10.1016/j.ejphar.2006.03.061
   PubMed Web of Science ®Google Scholar
• Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician. 2009;12(1):269–280. doi:10.36076/ppj.2009/12/269
   PubMed Web of Science ®Google Scholar
• Rao P, Knaus EE. Evolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyond. J Pharm Pharm Sci. 2008;11(2):81s–110s. doi:10.18433/J3T886
   PubMed Web of Science ®Google Scholar
• Nandakishore R, Yalavarthi PR, Kiran YR, Rajapranathi M. Selective cyclooxygenase inhibitors: current status. Curr Drug Discov Technol. 2014;11(2):127–132. doi:10.2174/1570163811666140127123717
   Google Scholar
• Yaksh TL, Dirig DM, Malmberg AB. Mechanism of action of nonsteroidal anti-inflammatory drugs. Cancer Invest. 1998;16(7):509–527. doi:10.3109/07357909809011705
   PubMed Web of Science ®Google Scholar
• Yaksh TL, Dirig DM, Conway CM, Svensson C, Luo ZD, Isakson PC. The acute antihyperalgesic action of nonsteroidal, anti-inflammatory drugs and release of spinal prostaglandin E2 is mediated by the inhibition of constitutive spinal cyclooxygenase-2 (COX-2) but not COX-1. J Neurosci. 2001;21(16):5847–5853. doi:10.1523/JNEUROSCI.21-16-05847.2001
   Web of Science ®Google Scholar
• Greco A, Ajmone-Cat MA, Nicolini A, Sciulli MG, Minghetti L. Paracetamol effectively reduces prostaglandin E2 synthesis in brain macrophages by inhibiting enzymatic activity of cyclooxygenase but not phospholipase and prostaglandin E synthase. J Neurosci Res. 2003;71(6):844–852. doi:10.1002/jnr.10543
   Web of Science ®Google Scholar
• Turman MV, Kingsley PJ, Marnett LJ. Characterization of an AM404 analogue, N-(3-hydroxyphenyl)arachidonoylamide, as a substrate and inactivator of prostaglandin endoperoxide synthase. Biochemistry. 2009;48(51):12233–12241. doi:10.1021/bi901181z
   Web of Science ®Google Scholar
• Saliba SW, Marcotegui AR, Fortwangler E, et al. AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. J Neuroinflammation. 2017;14(1):246. doi:10.1186/s12974-017-1014-3
   PubMed Web of Science ®Google Scholar
• Caballero FJ, Navarrete CM, Hess S, et al. The acetaminophen-derived bioactive N-acylphenolamine AM404 inhibits NFAT by targeting nuclear regulatory events. Biochem Pharmacol. 2007;73(7):1013–1023. doi:10.1016/j.bcp.2006.12.001
   Web of Science ®Google Scholar
• Zygmunt PM, Chuang -H-H, Movahed P, et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol. 2000;396(1):39–42. doi:10.1016/S0014-2999(00)00207-7
   PubMed Web of Science ®Google Scholar
• Stueber T, Meyer S, Jangra A, Hage A, Eberhardt M, Leffler A. Activation of the capsaicin-receptor TRPV1 by the acetaminophen metabolite N-arachidonoylaminophenol results in cytotoxicity. Life Sci. 2018;194:67–74. doi:10.1016/j.lfs.2017.12.024
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin W, Wu N, et al. An insight into paracetamol and its metabolites using molecular docking and molecular dynamics simulation. J Mol Model. 2018;24(9):243. doi:10.1007/s00894-018-3790-9
   Web of Science ®Google Scholar
• Nassini R, Materazzi S, Andre E, et al. Acetaminophen, via its reactive metabolite N-acetyl-p-benzo-quinoneimine and transient receptor potential ankyrin-1 stimulation, causes neurogenic inflammation in the airways and other tissues in rodents. FASEB J. 2010;24(12):4904–4916. doi:10.1096/fj.10-162438
   PubMed Web of Science ®Google Scholar
• De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V. Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett. 2000;483(1):52–56. doi:10.1016/S0014-5793(00)02082-2
   PubMed Web of Science ®Google Scholar
• Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 1997;277(5329):1094–1097. doi:10.1126/science.277.5329.1094
   PubMed Web of Science ®Google Scholar
• Howlett AC, Abood ME. CB1 and CB2 receptor pharmacology. Adv Pharmacol. 2017;80:169–206. doi:10.1016/bs.apha.2017.03.007
   PubMedGoogle Scholar
• Busquets-Garcia A, Bains J, Marsicano G. CB1 receptor signaling in the brain: extracting specificity from ubiquity. Neuropsychopharmacology. 2018;43(1):4–20. doi:10.1038/npp.2017.206
   Web of Science ®Google Scholar
• Fu J, Bottegoni G, Sasso O, et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci. 2011;15(1):64. doi:10.1038/nn.2986
   Web of Science ®Google Scholar
• Barriere DA, Mallet C, Blomgren A, et al. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. PLoS One. 2013;8(8):e70690. doi:10.1371/journal.pone.0070690
   PubMed Web of Science ®Google Scholar
• Evans RM, Scott RH, Ross RA. Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk. Br J Pharmacol. 2007;152(3):404–413. doi:10.1038/sj.bjp.0707411
   Web of Science ®Google Scholar
• Weinhold P, Gratzke C, Streng T, Stief C, Andersson KE, Hedlund P. TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol. 2010;183(5):2070–2076. doi:10.1016/j.juro.2009.12.093
   Web of Science ®Google Scholar
• Tanda G. Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. Psychopharmacology (Berl). 2016;233(10):1845–1866. doi:10.1007/s00213-016-4244-7
   Web of Science ®Google Scholar
• Tanda G, Goldberg SR. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms–a review of recent preclinical data. Psychopharmacology (Berl). 2003;169(2):115–134. doi:10.1007/s00213-003-1485-z
   PubMed Web of Science ®Google Scholar
• Nazarian A, Are D, Tenayuca JM. Acetaminophen modulation of hydrocodone reward in rats. Pharmacol Biochem Behav. 2011;99(3):307–310. doi:10.1016/j.pbb.2011.05.003
   Web of Science ®Google Scholar
• Jouanjus E, Guernec G, Lapeyre-Mestre M; French Addictovigilance N. Medical prescriptions falsified by the patients: a 12-year national monitoring to assess prescription drug diversion. Fundam Clin Pharmacol. 2018;32(3):306–322. doi:10.1111/fcp.12356
   PubMed Web of Science ®Google Scholar
• Suzuki R, Rahman W, Hunt SP, Dickenson AH. Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurones following peripheral nerve injury. Brain Res. 2004;1019(1–2):68–76. doi:10.1016/j.brainres.2004.05.108
   Web of Science ®Google Scholar
• Dupuis A, Wattiez AS, Pinguet J, et al. Increasing spinal 5-HT2A receptor responsiveness mediates anti-allodynic effect and potentiates fluoxetine efficacy in neuropathic rats. Evidence for GABA release. Pharmacol Res. 2017;118:93–103. doi:10.1016/j.phrs.2016.09.021
   Web of Science ®Google Scholar
• Miller KE, Salvatierra AT. Apposition of enkephalin- and neurotensin-immunoreactive neurons by serotonin-immunoreactive varicosities in the rat spinal cord. Neuroscience. 1998;85(3):837–846. doi:10.1016/S0306-4522(97)00522-8
   Web of Science ®Google Scholar
• Pini LA, Vitale G, Ottani A, Sandrini M. Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther. 1997;280(2):934–940.
   Web of Science ®Google Scholar
• Pickering G, Loriot MA, Libert F, Eschalier A, Beaune P, Dubray C. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006;79(4):371–378. doi:10.1016/j.clpt.2005.12.307
   PubMed Web of Science ®Google Scholar
• Durso GR, Luttrell A, Way BM. Way BM over-the-counter relief from pains and pleasures alike: acetaminophen blunts evaluation sensitivity to both negative and positive stimuli. Psychol Sci. 2015;26(6):750–758. doi:10.1177/0956797615570366
   PubMed Web of Science ®Google Scholar
• Dewall CN, Macdonald G, Webster GD, et al. Acetaminophen reduces social pain: behavioral and neural evidence. Psychol Sci. 2010;21(7):931–937. doi:10.1177/0956797610374741
   PubMed Web of Science ®Google Scholar
• Grundy L, Caldwell A, Brierley SM. Mechanisms underlying overactive bladder and interstitial cystitis/painful bladder syndrome. Front Neurosci. 2018;12:931. doi:10.3389/fnins.2018.00931
   PubMed Web of Science ®Google Scholar